The addition of all-trans retinoic acid to pembrolizumab conferred benefit to patients with metastatic melanoma, according to newly published research.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045
Pembrolizumab-ATRA Combination Shows Benefit in Metastatic Melanoma
Default sub title
minute read
by Healio | February 1, 2023
